Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14720
Articles
Company
Drug
Kelun-Biotech’s SKB264 Approved for Phase II Study in EGFR-Mutant NSCLC
January 25, 2025
Company
BeiGene Outlines Global R&D Strategy at J.P. Morgan Healthcare Summit
January 25, 2025
Company
Deals
Evopoint Biosciences Licenses SOS1 Inhibitor to METiS Therapeutics
January 25, 2025
Company
Drug
Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone
January 25, 2025
Company
Deals
HKEX 2022 Annual Report: IPO Activity Declines Amid Global Challenges
January 25, 2025
Company
Drug
Konruns Initiates Phase II Study for KC1036 in Advanced Thymic Tumors
January 25, 2025
Company
Drug
Dizal’s Sunvozertinib NDA Accepted for Review by China’s NMPA
January 25, 2025
Company
Drug
HighTide Therapeutics Doses First Patient in Phase IIb Study for HTD1801 in NASH
January 25, 2025
Drug
MSD Submits Initial Quotation for Molnupiravir in China Amid New COVID-19 Rules
January 25, 2025
Company
Drug
Treadwell Therapeutics’ CFI-402257 Granted Fast-Track Status by FDA
January 25, 2025
Policy / Regulatory
CDE Releases 66th Batch of Chemical Generic Reference Preparations
January 25, 2025
Company
Drug
Jiangsu Kanion’s KYS202002A Greenlit for Clinical Study in Multiple Myeloma
January 25, 2025
1
2
…
1,075
1,076
1,077
1,078
1,079
…
1,226
1,227
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?